COMMUNIQUÉS West-GlobeNewswire

Ossur Hf : Interim report Q2 2018

26/07/2018 - 08:01

Announcement no. 47/2018 Interim report Q2 2018 26 July 2018 Highlights Sales amounted to USD 158 million, corresponding to 9% USD growth and 6% organic growth. Sales for 1H 2018 amounted to USD 300 million, [...]

Financière de Tubize SA: Half-year Financial Report 2018

26/07/2018 - 08:01

Press release 26 July 2018 Embargo till 08:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Brussels Contact: Anne Sophie Pijcke, day-to-day management, aspijcke@icloud.com 2018 half-year financial report [...]

Financière de Tubize SA: Rapport financier semestriel 2018

26/07/2018 - 08:01

Communiqué de presse 26 juillet 2018 Embargo jusqu'à 08:00h CET FINANCIERE DE TUBIZE SA Allée de la Recherche 60, 1070 Bruxelles Contact: Anne Sophie Pijcke, directeur, aspijcke@icloud.com Rapport financier semestriel [...]

Shire plc : Rule 2.9 Announcement

26/07/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 26 July 2018 Shire [...]

DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer

26/07/2018 - 07:31

Montrouge, France, July 26, 2018 DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer Demonstrated track record of success instrumental in preparing for potential Viaskin Peanut launch in [...]

Nomination d'un professionnel reconnu de l'industrie Kevin Trapp au poste de Directeur Commercial de DBV Technologies

26/07/2018 - 07:31

Montrouge, France, le 26 juillet (07H30 CEST), 2018 Nomination d'un professionnel reconnu de l'industrie Kevin Trapp au poste de Directeur Commercial de DBV Technologies Sa grande expérience dans le lancement réussi de [...]

Sanofi Head of Human Resources Roberto Pucci to retire; Company names Caroline Luscombe to take over October 1st

26/07/2018 - 07:02

Sanofi Head of Human Resources Roberto Pucci to retire; Company names Caroline Luscombe to take over October 1 st Paris - July 26, 2018 - Roberto Pucci, Head of Human Resources, will retire from Sanofi after more than 9 [...]

Départ à la retraite de Roberto Pucci, Responsable des Ressources Humaines de Sanofi ; l'entreprise nomme Caroline Luscombe pour lui succéder à compter du 1er octobre

26/07/2018 - 07:02

Départ à la retraite de Roberto Pucci, Responsable des Ressources Humaines de Sanofi ; l'entreprise nomme Caroline Luscombe pour lui succéder à compter du 1 er octobre Paris - Le 26 juillet 2018 - Roberto Pucci, [...]

argenx to host conference call & webcast to report second quarter business update and half year 2018 financial results on August 2, 2018

26/07/2018 - 07:01

Management to host conference call today at 3 p.m. CEST / 9 a.m. EDT July 26, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep [...]

Essilor - News Release: Strong Second Quarter, Delivering on the Growth Strategy

26/07/2018 - 06:31

Strong Second Quarter Delivering on the Growth Strategy PDF version of the news release On track with objectives: First-half like-for-like growth 1 of 4.0%, including 4.8% in Q2, and contribution from operations 2 at 18 [...]

Essilor - Communiqué : Très bon deuxième trimestre, Stratégie de croissance porteuse

26/07/2018 - 06:31

Très bon deuxième trimestre Stratégie de croissance porteuse Version PDF du communiqué S1 en ligne avec les objectifs : croissance en base homogène 1 de 4,0 % (dont 4,8 % au T2) et contribution de l'activité 2 à 18,4 % [...]

Essilor - News Release: Publication of the 2018 Interim Financial Report

26/07/2018 - 06:31

Publication of the 2018 Interim Financial Report PDF version of the news release Charenton-le-Pont, France (July 26, 2018 - 6:30 am) - The Essilor International (Compagnie Générale d'Optique) 2018 Interim Financial [...]

Essilor - Communiqué : Mise à disposition du rapport financier semestriel 2018

26/07/2018 - 06:31

Mise à disposition du rapport financier semestriel 2018 Version PDF du communiqué Charenton-le-Pont, France (le 26 juillet 2018 - 06h30) - Essilor International (Compagnie Générale d'Optique) publie ce matin son rapport [...]

REVA Enters Peripheral Artery Disease Space With First-Ever CE Mark of a Bioresorbale Scaffold for Below the Knee Therapy

26/07/2018 - 01:15

SAN DIEGO, July 25, 2018 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, today announced that its MOTIV™ [...]

Telix Pharmaceuticals and JFE Progress Japanese Manufacturing Partnership

26/07/2018 - 01:00

MELBOURNE, Australia and TOKYO, July 26, 2018 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX:TLX) (“ Telix ”, the “ Company ”), an Australian biopharmaceutical company focused on the development of diagnostic [...]

R1 RCM to Release Second Quarter 2018 Results on August 9

26/07/2018 - 00:24

CHICAGO, July 25, 2018 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of technology-enabled revenue cycle management (RCM) services to healthcare providers, today announced it expects to release [...]

Merit Medical Announces Pricing of Public Offering of Common Stock

26/07/2018 - 00:20

SOUTH JORDAN, Utah, July 25, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) (“ Merit ”), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and [...]

BioCryst Announces Publication of APeX-1 Clinical Trial Results for BCX7353 in The New England Journal of Medicine

26/07/2018 - 00:00

73.8% reduction in attacks with significant benefits in quality of life from once-daily oral dosing of BCX7353 125 mg RESEARCH TRIANGLE PARK, N.C., July 25, 2018 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. ( [...]

New Phase 2 Data Analysis for Crenezumab Presented at Global Alzheimer's Conference Provides Strong Evidence for Engagement of the Principle Abeta Target

25/07/2018 - 23:55

Crenezumab significantly reduces Abeta oligomers in cerebrospinal fluid (CSF) in patients with Alzheimer's disease Strong evidence for principal target engagement of Abeta oligomers, the most neurotoxic species of the [...]